Over the 90-day window ending December 12, 2025, Intellia Therapeutics's three dominant insider ownership positions are held by EVP And Chief Scientific Officer Birgit C Schultes (105.18K shares), VP And Chief Accounting Officer Michael P Dube (55.27K shares), Director Georgia Keresty (31.88K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| John M Leonard | President And CEO | 1,047,485 | 12 Dec, 2025 |
| Jose E Rivera | EVP And General Counsel | 162,388 | 02 Apr, 2021 |
| William J Chase | 134,693 | 22 Aug, 2025 | |
| David Lebwohl | EVP And Chief Medical Officer | 130,866 | 04 Mar, 2025 |
| James Basta | EVP And General Counsel | 111,925 | 04 Mar, 2025 |
| Edward J Iii Dulac | EVP And Chief Financial Officer | 106,062 | 25 Jul, 2025 |
| Birgit C Schultes | EVP And Chief Scientific Officer | 105,184 | 03 Oct, 2025 |
| Eliana Clark | EVP And Chief Technical Officer | 95,369 | 03 Jul, 2025 |
| Laura Sepp-Lorenzino | EVP And Chief Scientific Officer | 77,388 | 07 Jan, 2025 |
| Glenn Goddard | EVP And Chief Financial Officer | 69,213 | 05 Mar, 2024 |
| Derek Hicks | EVP And Chief Business Officer | 59,878 | 07 Jan, 2025 |
| Fred E Cohen | 57,453 | 13 Jun, 2025 | |
| Michael P Dube | VP And Chief Accounting Officer | 55,266 | 03 Oct, 2025 |
| Georgia Keresty | 31,883 | 18 Jun, 2025 | |
| Muna Bhanji | 27,203 | 13 Jun, 2025 | |
| Frank Verwiel | 25,948 | 13 Jun, 2025 | |
| Jesse Goodman | 24,359 | 02 Jul, 2025 | |
| Brian Goff | 23,409 | 13 Jun, 2025 | |
| Jean Francois Formela | 17,291 | 16 Jun, 2022 | |
| Andrew Schiermeier | EVP And Chief Operating Officer | 16,656 | 05 Jan, 2021 |
| Caroline Dorsa | 12,701 | 16 Jun, 2022 | |
| John F Crowley | 11,716 | 16 Jun, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Dec, 2025 | John M Leonard | Common Stock | A | 49,959 | $6.83 | 1,127,074 | D | M |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 49,959 | $9.49 | 1,077,115 | D | S |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 32,832 | $9.47 | 1,044,283 | D | S |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 5,355 | $9.59 | 1,038,928 | D | S |
| 12 Dec, 2025 | John M Leonard | Common Stock | A | 8,557 | $6.83 | 1,047,485 | D | M |
| 01 Oct, 2025 | Birgit C Schultes | Common Stock | D | 31 | $17.38 | 105,184 | D | S |
| 01 Oct, 2025 | Michael P Dube | Common Stock | D | 1,871 | $17.38 | 55,266 | D | S |
| 20 Aug, 2025 | William J Chase | Common Stock | A | 100,000 | $10.03 | 134,693 | D | P |
| 20 Aug, 2025 | William J Chase | - | - | 134,693 | D | |||
| 23 Jul, 2025 | Edward J Iii Dulac | - | - | 106,062 | D | |||
| 23 Jul, 2025 | Edward J Iii Dulac | Common Stock | D | 7,462 | $14.02 | 106,062 | D | S |
| 02 Jul, 2025 | Michael P Dube | Common Stock | D | 2,503 | $9.95 | 57,137 | D | S |
| 01 Jul, 2025 | Eliana Clark | Common Stock | D | 1,022 | $9.82 | 95,369 | D | S |
| 01 Jul, 2025 | Eliana Clark | - | - | 95,369 | D | |||
| 30 Jun, 2025 | Jesse Goodman | Common Stock | D | 1,547 | $9.56 | 25,906 | D | S |
| 01 Jul, 2025 | Jesse Goodman | Common Stock | D | 1,547 | $9.23 | 24,359 | D | S |
| 01 Jul, 2025 | Jesse Goodman | - | - | 24,359 | D | |||
| 11 Jun, 2025 | Frank Verwiel | Common Stock | A | 8,000 | $0.00 | 25,948 | D | A |
| 11 Jun, 2025 | Brian Goff | Common Stock | A | 8,000 | $0.00 | 23,409 | D | A |
| 11 Jun, 2025 | Jesse Goodman | Common Stock | A | 8,000 | $0.00 | 27,453 | D | A |